Document Detail


Progression of retinopathy in persons with type 2 diabetes: new data, same conclusions?
MedLine Citation:
PMID:  20980947     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial was designed primarily to examine the effects of intensive glycemic control on cardiovascular events in persons with type 2 diabetes who were, for additional reasons, at high risk for such events. The trial also examined effects on the same endpoints of intervention on blood pressure and on serum lipids. The study intervention on glycemic control was stopped early because of the effects of this intervention on mortality. The trial provided important data on the effects of the various interventions on diabetic retinopathy, confirming the importance of intensive glycemic control in diminishing the progression of retinopathy. In addition, it provided evidence of a protective effect of fenofibrate treatment on the same retinopathy endpoint. However, the apparent paradoxical effects of intensive glycemic control on macrovascular and microvascular disease suggests caution in the care of persons with type 2 diabetes who are judged to be at high risk for cardiovascular events.
Authors:
Barbara E K Klein
Related Documents :
19179817 - The renoprotective effects of ras inhibition: focus on prevention and treatment of chro...
20404727 - Metabolic sequelae associated with androgen deprivation therapy for prostate cancer.
15539107 - Insights into the biology of diabetic vascular disease: what's new?
11755507 - The effect of interventions to prevent cardiovascular disease in patients with type 2 d...
7869127 - Concentrations of thiocyanate and hypothiocyanite in the saliva of young adults.
11225967 - Physiological responses during hypoglycaemia induced by regular human insulin or a nove...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Polskie Archiwum Medycyny Wewnętrznej     Volume:  120     ISSN:  1897-9483     ISO Abbreviation:  Pol. Arch. Med. Wewn.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401225     Medline TA:  Pol Arch Med Wewn     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  413-6     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53726-2336, United States. kleinb@epi.ophth.wisc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
EY016379/EY/NEI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aspirin chemoprevention of gastrointestinal cancer in the next decade. A review of the evidence.
Next Document:  How should we treat tuberculosis in adult patients with chronic kidney disease? Key messages from th...